Ono Pharmaceutical Co., Ltd. has partnered with Phylo, Inc. to integrate agentic AI technology into its drug discovery operations for research scientists. The collaboration aims to enhance the efficiency and capabilities of Ono’s discovery scientists through AI-powered tools embedded in their workflow.